https://www.sciencehubpro.com/ 2025-03-19T17:30:30+00:00 daily 1.0 https://www.sciencehubpro.com/ch 2025-03-19T17:30:30+00:00 daily 1.0 https://www.sciencehubpro.com/pt 2025-03-19T17:30:30+00:00 daily 1.0 https://www.sciencehubpro.com/privacy-policy 2023-07-18T07:21:59+00:00 0.5 https://www.sciencehubpro.com/ch/privacy-policy 2023-07-18T07:21:59+00:00 0.5 https://www.sciencehubpro.com/pt/privacy-policy 2023-07-18T07:21:59+00:00 0.5 https://www.sciencehubpro.com/terms-use 2024-12-23T13:50:30+00:00 0.5 https://www.sciencehubpro.com/ch/terms-of-use 2024-12-23T13:50:30+00:00 0.5 https://www.sciencehubpro.com/pt/terms-of-use 2024-12-23T13:50:30+00:00 0.5 https://www.sciencehubpro.com/cookie-policy 2023-06-13T14:00:57+00:00 0.5 https://www.sciencehubpro.com/ch/cookie-policy 2023-06-13T14:00:57+00:00 0.5 https://www.sciencehubpro.com/pt/cookie-policy 2023-06-13T14:00:57+00:00 0.5 https://www.sciencehubpro.com/404 2023-06-14T06:38:29+00:00 0.5 https://www.sciencehubpro.com/ch/404 2023-06-14T06:38:29+00:00 0.5 https://www.sciencehubpro.com/pt/404 2023-06-14T06:38:29+00:00 0.5 https://www.sciencehubpro.com/medical-information-request 2025-08-07T08:56:43+00:00 0.5 https://www.sciencehubpro.com/ch/medical-information-request 2025-08-07T08:56:43+00:00 0.5 https://www.sciencehubpro.com/pt/medical-information-request 2025-08-07T08:56:43+00:00 0.5 https://www.sciencehubpro.com/adverse-event-reporting 2023-06-13T08:13:18+00:00 0.5 https://www.sciencehubpro.com/ch/adverse-event-reporting 2023-06-13T08:13:18+00:00 0.5 https://www.sciencehubpro.com/pt/adverse-event-reporting 2023-06-13T08:13:18+00:00 0.5 https://www.sciencehubpro.com/product-quality-complaint-report 2023-06-13T09:38:50+00:00 0.5 https://www.sciencehubpro.com/ch/product-quality-complaint-report 2023-06-13T09:38:50+00:00 0.5 https://www.sciencehubpro.com/pt/product-quality-complaint-report 2023-06-13T09:38:50+00:00 0.5 https://www.sciencehubpro.com/home 2025-03-19T17:30:30+00:00 0.5 https://www.sciencehubpro.com/ch/home 2025-03-19T17:30:30+00:00 0.5 https://www.sciencehubpro.com/pt/about-vifor-pharma-science-hub 2025-03-19T17:30:30+00:00 0.5 https://www.sciencehubpro.com/not-access 2023-07-05T08:19:41+00:00 0.5 https://www.sciencehubpro.com/successfully-registered 2023-07-05T08:21:55+00:00 0.5 https://www.sciencehubpro.com/ch/successfully-registered 2023-07-05T08:21:55+00:00 0.5 https://www.sciencehubpro.com/pt/successfully-registered 2023-07-05T08:21:55+00:00 0.5 https://www.sciencehubpro.com/opt-in 2023-07-05T08:23:18+00:00 0.5 https://www.sciencehubpro.com/ch/articles/iron-supplementation-in-patients-with-hf-how-when-and-in-which-patients 2024-07-19T19:02:04+00:00 0.5 https://www.sciencehubpro.com/pt/articles/iron-supplementation-in-patients-with-hf-how-when-and-in-which-patients 2024-07-19T19:02:04+00:00 0.5 https://www.sciencehubpro.com/ch/articles/rationale-for-raising-the-25-ohd-target-to-50-ng-ml-in-nd-ckd-patients 2024-12-05T15:34:10+00:00 0.5 https://www.sciencehubpro.com/pt/articles/rationale-for-raising-the-25-ohd-target-to-50-ng-ml-in-nd-ckd-patients 2024-12-05T15:34:10+00:00 0.5 https://www.sciencehubpro.com/ch/articles/optimal-anemia-management-in-patients-with-ckd-a-new-paradigm-in-treatment 2024-07-19T19:02:04+00:00 0.5 https://www.sciencehubpro.com/pt/articles/optimal-anemia-management-in-patients-with-ckd-a-new-paradigm-in-treatment 2024-07-19T19:02:04+00:00 0.5 https://www.sciencehubpro.com/articles/symptom-based-complications-in-patients-undergoing-dialysis 2023-03-30T13:30:12+00:00 0.5 https://www.sciencehubpro.com/ch/articles/symptom-based-complications-in-patients-undergoing-dialysis 2023-03-30T13:30:12+00:00 0.5 https://www.sciencehubpro.com/pt/articles/symptom-based-complications-in-patients-undergoing-dialysis 2023-03-30T13:30:12+00:00 0.5 https://www.sciencehubpro.com/articles/unmet-medical-needs-in-patients-with-ckd-ap-era-edta-symposium-2021 2023-07-05T09:25:30+00:00 0.5 https://www.sciencehubpro.com/ch/articles/unmet-medical-needs-in-patients-with-ckd-ap-era-edta-symposium-2021 2023-07-05T09:25:30+00:00 0.5 https://www.sciencehubpro.com/pt/articles/unmet-medical-needs-in-patients-with-ckd-ap-era-edta-symposium-2021 2023-07-05T09:25:30+00:00 0.5 https://www.sciencehubpro.com/articles/the-hyperkalemia-challenge-in-patients-with-ckd 2024-02-15T18:43:24+00:00 0.5 https://www.sciencehubpro.com/ch/articles/the-hyperkalemia-challenge-in-patients-with-ckd 2024-02-15T18:43:24+00:00 0.5 https://www.sciencehubpro.com/pt/articles/the-hyperkalemia-challenge-in-patients-with-ckd 2024-02-15T18:43:24+00:00 0.5 https://www.sciencehubpro.com/ch/articles/kdigo-2020-guidelines-for-diabetes-management-in-ckd-patients 2024-12-05T15:25:17+00:00 0.5 https://www.sciencehubpro.com/pt/articles/kdigo-2020-guidelines-for-diabetes-management-in-ckd-patients 2024-12-05T15:25:17+00:00 0.5 https://www.sciencehubpro.com/articles/latest-kdigo-guidelines-support-the-use-of-k-plus-binders-in-chronic-hyperkalemia 2023-07-05T09:25:54+00:00 0.5 https://www.sciencehubpro.com/ch/articles/latest-kdigo-guidelines-support-the-use-of-k-plus-binders-in-chronic-hyperkalemia 2023-07-05T09:25:54+00:00 0.5 https://www.sciencehubpro.com/pt/articles/latest-kdigo-guidelines-support-the-use-of-k-plus-binders-in-chronic-hyperkalemia 2023-07-05T09:25:54+00:00 0.5 https://www.sciencehubpro.com/ch/articles/unmet-needs-in-the-treatment-of-SHPT 2024-12-05T15:27:53+00:00 0.5 https://www.sciencehubpro.com/pt/articles/unmet-needs-in-the-treatment-of-SHPT 2024-12-05T15:27:53+00:00 0.5 https://www.sciencehubpro.com/ch/articles/practical-approaches-to-SHPT-management-in-patients-with-ND-CKD 2024-12-05T15:31:29+00:00 0.5 https://www.sciencehubpro.com/pt/articles/practical-approaches-to-SHPT-management-in-patients-with-ND-CKD 2024-12-05T15:31:29+00:00 0.5 https://www.sciencehubpro.com/articles/emerging-opportunities-and-challenges-in-SHPT 2023-03-30T13:15:49+00:00 0.5 https://www.sciencehubpro.com/ch/articles/emerging-opportunities-and-challenges-in-SHPT 2023-03-30T13:15:49+00:00 0.5 https://www.sciencehubpro.com/pt/articles/emerging-opportunities-and-challenges-in-SHPT 2023-03-30T13:15:49+00:00 0.5 https://www.sciencehubpro.com/ch/articles/establishing-25-OHD-level-adequacy-in-patients-with-ND-CKD 2024-12-05T15:29:01+00:00 0.5 https://www.sciencehubpro.com/pt/articles/establishing-25-OHD-level-adequacy-in-patients-with-ND-CKD 2024-12-05T15:29:01+00:00 0.5 https://www.sciencehubpro.com/ch/articles/iron-therapy-in-patients-with-hf-preclinical-data 2024-07-19T19:02:04+00:00 0.5 https://www.sciencehubpro.com/pt/articles/iron-therapy-in-patients-with-hf-preclinical-data 2024-07-19T19:02:04+00:00 0.5 https://www.sciencehubpro.com/ch/articles/health-related-qol-in-patients-with-acute-hf 2024-07-19T19:02:04+00:00 0.5 https://www.sciencehubpro.com/pt/articles/health-related-qol-in-patients-with-acute-hf 2024-07-19T19:02:04+00:00 0.5 https://www.sciencehubpro.com/ch/articles/unmet-medical-needs-in-patients-with-ckd-ap-emj-nephrology-review 2024-07-19T19:03:29+00:00 0.5 https://www.sciencehubpro.com/pt/articles/unmet-medical-needs-in-patients-with-ckd-ap-emj-nephrology-review 2024-07-19T19:03:29+00:00 0.5 https://www.sciencehubpro.com/ch/articles/kdigo-2021-guidelines-for-blood-pressure-management-in-ckd-patients 2024-12-05T15:35:17+00:00 0.5 https://www.sciencehubpro.com/pt/articles/kdigo-2021-guidelines-for-blood-pressure-management-in-ckd-patients 2024-12-05T15:35:17+00:00 0.5 https://www.sciencehubpro.com/articles/emerging-opportunities-and-challenges-in-shpt-management-in-nd-ckd-patients 2023-03-30T13:32:52+00:00 0.5 https://www.sciencehubpro.com/ch/articles/emerging-opportunities-and-challenges-in-shpt-management-in-nd-ckd-patients 2023-03-30T13:32:52+00:00 0.5 https://www.sciencehubpro.com/pt/articles/emerging-opportunities-and-challenges-in-shpt-management-in-nd-ckd-patients 2023-03-30T13:32:52+00:00 0.5 https://www.sciencehubpro.com/ch/articles/aav-disease-awareness-mod-video 2024-12-05T15:32:19+00:00 0.5 https://www.sciencehubpro.com/pt/articles/aav-disease-awareness-mod-video 2024-12-05T15:32:19+00:00 0.5 https://www.sciencehubpro.com/articles/exploring-the-unmet-needs-of-people-suffering-with-ANCA-associated-vasculitis-AAV 2024-02-15T18:33:52+00:00 0.5 https://www.sciencehubpro.com/ch/articles/exploring-the-unmet-needs-of-people-suffering-with-ANCA-associated-vasculitis-AAV 2024-02-15T18:33:52+00:00 0.5 https://www.sciencehubpro.com/pt/articles/exploring-the-unmet-needs-of-people-suffering-with-ANCA-associated-vasculitis-AAV 2024-02-15T18:33:52+00:00 0.5 https://www.sciencehubpro.com/ch/articles/anca-2022-symposia-transforming-outcomes-in-AAV-by-targeting-C5aR-mediated-inflammation 2024-12-09T16:37:54+00:00 0.5 https://www.sciencehubpro.com/pt/articles/anca-2022-symposia-transforming-outcomes-in-AAV-by-targeting-C5aR-mediated-inflammation 2024-12-09T16:37:54+00:00 0.5 https://www.sciencehubpro.com/articles/compassionate-use-of-avacopan-in-difficult-to-treat-anca-associated-vasculitis 2023-07-05T09:27:17+00:00 0.5 https://www.sciencehubpro.com/ch/articles/compassionate-use-of-avacopan-in-difficult-to-treat-anca-associated-vasculitis 2023-07-05T09:27:17+00:00 0.5 https://www.sciencehubpro.com/pt/articles/compassionate-use-of-avacopan-in-difficult-to-treat-anca-associated-vasculitis 2023-07-05T09:27:17+00:00 0.5 https://www.sciencehubpro.com/articles/avacopan-as-first-line-treatment-in-antineutrophil-cytoplasmic-antibody-associated-vasculitis-a-steroid-sparing-option 2023-07-05T09:25:42+00:00 0.5 https://www.sciencehubpro.com/ch/articles/avacopan-as-first-line-treatment-in-antineutrophil-cytoplasmic-antibody-associated-vasculitis-a-steroid-sparing-option 2023-07-05T09:25:42+00:00 0.5 https://www.sciencehubpro.com/pt/articles/avacopan-as-first-line-treatment-in-antineutrophil-cytoplasmic-antibody-associated-vasculitis-a-steroid-sparing-option 2023-07-05T09:25:42+00:00 0.5 https://www.sciencehubpro.com/articles/optimization-of-raasi-and-low-risk-of-hyperkalemia-with-potassium-binder-in-hfref 2023-07-05T09:27:26+00:00 0.5 https://www.sciencehubpro.com/ch/articles/optimization-of-raasi-and-low-risk-of-hyperkalemia-with-potassium-binder-in-hfref 2023-07-05T09:27:26+00:00 0.5 https://www.sciencehubpro.com/pt/articles/optimization-of-raasi-and-low-risk-of-hyperkalemia-with-potassium-binder-in-hfref 2023-07-05T09:27:26+00:00 0.5 https://www.sciencehubpro.com/ch/articles/the-science-of-complement-antagonism-in-anca-vasculitis-current-understanding 2024-12-05T15:21:32+00:00 0.5 https://www.sciencehubpro.com/pt/articles/the-science-of-complement-antagonism-in-anca-vasculitis-current-understanding 2024-12-05T15:21:32+00:00 0.5 https://www.sciencehubpro.com/ch/articles/early-intervention-for-secondary-hyperparathyroidism-in-patients-with-non-dialysis-CKD 2024-12-05T15:14:24+00:00 0.5 https://www.sciencehubpro.com/pt/articles/early-intervention-for-secondary-hyperparathyroidism-in-patients-with-non-dialysis-CKD 2024-12-05T15:14:24+00:00 0.5 https://www.sciencehubpro.com/ch/articles/shift-in-focus-international-insights-into-the-optimal-management-of-ckd-mbd 2024-12-05T15:20:01+00:00 0.5 https://www.sciencehubpro.com/pt/articles/shift-in-focus-international-insights-into-the-optimal-management-of-ckd-mbd 2024-12-05T15:20:01+00:00 0.5 https://www.sciencehubpro.com/articles/guiding-you-through-glomerular-disease-an-interactive-approach-to-learning-more-on-igan-and-fsgs 2023-12-13T19:36:28+00:00 0.5 https://www.sciencehubpro.com/ch/articles/guiding-you-through-glomerular-disease-an-interactive-approach-to-learning-more-on-igan-and-fsgs 2023-12-13T19:36:28+00:00 0.5 https://www.sciencehubpro.com/pt/articles/guiding-you-through-glomerular-disease-an-interactive-approach-to-learning-more-on-igan-and-fsgs 2023-12-13T19:36:28+00:00 0.5 https://www.sciencehubpro.com/articles/igan-mechanism-of-disease 2024-03-18T14:32:24+00:00 0.5 https://www.sciencehubpro.com/ch/articles/igan-mechanism-of-disease 2024-03-18T14:32:24+00:00 0.5 https://www.sciencehubpro.com/pt/articles/igan-mechanism-of-disease 2024-03-18T14:32:24+00:00 0.5 https://www.sciencehubpro.com/ch/articles/fsgs-mechanism-of-disease 2024-12-05T15:24:05+00:00 0.5 https://www.sciencehubpro.com/pt/articles/fsgs-mechanism-of-disease 2024-12-05T15:24:05+00:00 0.5 https://www.sciencehubpro.com/study/cardiovascular-and-renal-treatment-in-heart-failure-patients-with-hyperkalemia-or-at-high-risk-of-hyperkalemia 2023-04-03T12:14:06+00:00 0.5 https://www.sciencehubpro.com/ch/study/cardiovascular-and-renal-treatment-in-heart-failure-patients-with-hyperkalemia-or-at-high-risk-of-hyperkalemia 2023-04-03T12:14:06+00:00 0.5 https://www.sciencehubpro.com/pt/study/cardiovascular-and-renal-treatment-in-heart-failure-patients-with-hyperkalemia-or-at-high-risk-of-hyperkalemia 2023-04-03T12:14:06+00:00 0.5 https://www.sciencehubpro.com/study/ERC-non-interventional-study-NIS-on-effectiveness-ND-CKD-SHPT-patients 2023-04-03T11:51:09+00:00 0.5 https://www.sciencehubpro.com/ch/study/ERC-non-interventional-study-NIS-on-effectiveness-ND-CKD-SHPT-patients 2023-04-03T11:51:09+00:00 0.5 https://www.sciencehubpro.com/pt/study/ERC-non-interventional-study-NIS-on-effectiveness-ND-CKD-SHPT-patients 2023-04-03T11:51:09+00:00 0.5 https://www.sciencehubpro.com/ch/articles/abbreviated-smp-for-difelikefalin 2023-07-05T09:45:16+00:00 0.5 https://www.sciencehubpro.com/ch/articles/diagnostic-of-iron-deficiency-for-laboratory-analysis 2023-07-05T09:44:45+00:00 0.5 https://www.sciencehubpro.com/ch/articles/pocketcard-2022-of-swiss-heart-failure-recommendations 2023-07-05T09:45:03+00:00 0.5 https://www.sciencehubpro.com/ch/articles/new-opinion-from-who-on-patient-blood-management 2023-07-05T09:44:56+00:00 0.5 https://www.sciencehubpro.com/ch/articles/innovative-pbm-project-of-the-ticino-hospital-network 2023-07-05T09:45:10+00:00 0.5 https://www.sciencehubpro.com/ch/articles/extended-release-calcifediol-erc-in-secondary-hyperparathyroidism-shpt-a-new-option-that-challenges-the-current-therapeutic-approach-from-studies-to-your-clinical-practice 2023-07-05T09:44:37+00:00 0.5 https://www.sciencehubpro.com/node/391 2023-06-21T13:06:45+00:00 0.5 https://www.sciencehubpro.com/articles/proteinuria-fact-sheet 2025-06-13T22:50:41+00:00 0.5 https://www.sciencehubpro.com/articles/iga-nephropathy-igan-explained-1-pager 2025-06-13T22:53:51+00:00 0.5 https://www.sciencehubpro.com/articles/immunoglobulin-nephropathy-igan-explained-educational-presentation 2025-06-13T22:55:17+00:00 0.5 https://www.sciencehubpro.com/articles/endothelin-1-et-1-and-angiotensin-ii-ang-ii-iga-nephropathy-igan-educational-presentation 2025-06-13T22:57:19+00:00 0.5 https://www.sciencehubpro.com/articles/target-proteinuria-iga-nephropathy-igan 2025-06-13T22:58:09+00:00 0.5 https://www.sciencehubpro.com/articles/advancing-therapeutic-goals-iga-nephropathy 2025-06-13T22:59:04+00:00 0.5 https://www.sciencehubpro.com/articles/endothelin-1-et-1-and-angiotensin-ii-ang-ii-iga-nephropathy-igan-video 2025-08-05T12:21:34+00:00 0.5 https://www.sciencehubpro.com/ch/articles/WebinarUpdateforgeneralpractitionersMarch 2024-05-29T14:39:31+00:00 0.5 https://www.sciencehubpro.com/ch/articles/Introduction-to-IgAN 2024-11-21T21:27:59+00:00 0.5 https://www.sciencehubpro.com/ch/articles/Unmet-need-in-IgAN 2024-11-21T21:28:23+00:00 0.5 https://www.sciencehubpro.com/ch/articles/3-minutes-to-deep-dive-into-the-pathophysiology-of-IgAN-and-why-proteinuria-matters 2024-11-21T21:29:03+00:00 0.5 https://www.sciencehubpro.com/ch/articles/learnin-2-minutes-endothelin-and-RAS-pathway-in-IgAN 2025-09-02T07:26:23+00:00 0.5 https://www.sciencehubpro.com/ch/articles/Innovative-Ans%C3%A4tze-zur-IgAN-Therapie-Vortrag-von-Prof.-Huynh-Do 2026-03-12T15:41:32+00:00 0.5 https://www.sciencehubpro.com/ch/articles/New-treatment-options-for-IgAN-along-with-real-world-data-for-sparsentan-Comprehensive-review-by-Prof.JoergLatus 2024-11-21T21:26:34+00:00 0.5 https://www.sciencehubpro.com/ch/articles/Relative-vaccine-effectiveness-of-cell-%20vs%20egg-based-quadrivalent-influenza-vaccine-against-test-confirmed-influenza-over-3-seasons-between-2017-and-2020-in-the-UnitedStates 2024-12-09T06:24:20+00:00 0.5 https://www.sciencehubpro.com/ch/articles/review-collection-important-research-avacopan 2025-01-14T14:44:35+00:00 0.5 https://www.sciencehubpro.com/ch/articles/explore-unmet-needs-aav-patients 2025-01-14T14:03:51+00:00 0.5 https://www.sciencehubpro.com/ch/articles/Infographic-of-testosterone-deficiency-its-symptoms-diagnosis-and-treatment 2025-03-20T14:15:29+00:00 0.5 https://www.sciencehubpro.com/ch/articles/innovation-influenza-vaccination-switzerland-role-cell-based-vaccines 2025-05-14T11:38:54+00:00 0.5 https://www.sciencehubpro.com/ch/articles/dont-miss-it-rapid-accurate-aav-diagnosis-cme-reachmd-dr-silke-brix-and-dr-andreas 2025-04-03T13:20:19+00:00 0.5 https://www.sciencehubpro.com/ch/articles/implementing-soc-induction-therapies-aav-cme-reachmd-dr-silke-brix-and-dr-bernhard 2025-04-03T13:18:53+00:00 0.5 https://www.sciencehubpro.com/ch/articles/optimizing-aav-outcomes-maintenance-therapies-cme-reachmd-dr-silke-brix-and-dr-bernhard 2025-04-03T13:17:55+00:00 0.5 https://www.sciencehubpro.com/ch/articles/tailoring-treatment-optimal-outcomes-patients-aav-cme-reachmd-dr-bernhard-hellmich-and-dr 2025-04-03T13:23:49+00:00 0.5 https://www.sciencehubpro.com/ch/articles/elevating-care-patients-severe-renal-disease-aav-cme-reachmd-dr-bernhard-hellmich-and-dr 2025-04-03T13:30:37+00:00 0.5 https://www.sciencehubpro.com/ch/articles/managing-patients-aav-rheumatology-clinic-cme-reachmd-dr-bernhard-hellmich-and-dr-andreas 2025-04-03T13:33:44+00:00 0.5 https://www.sciencehubpro.com/ch/articles/robust-evidence-cardiovascular-safety-testosterone-replacement-therapy 2025-04-03T13:50:43+00:00 0.5 https://www.sciencehubpro.com/ch/articles/depressive-syndromes-men-hypogonadism-impact-testosterone-replacement-therapy 2025-04-03T14:03:11+00:00 0.5 https://www.sciencehubpro.com/ch/articles/traverse-study-redefining-what-we-knew-about-safety-profile-testosterone-replacement 2025-04-03T14:37:40+00:00 0.5 https://www.sciencehubpro.com/ch/articles/robust-evidence-safety-testosterone-replacement-therapy-pre-diabetic-and-diabetic-patients 2025-04-03T14:41:02+00:00 0.5 https://www.sciencehubpro.com/ch/articles/robust-evidence-testosterone-replacement-therapy-prevention-and-correction-anaemia-men 2025-04-03T14:43:59+00:00 0.5 https://www.sciencehubpro.com/ch/articles/robust-evidence-prostate-safety-testosterone-replacement-therapy 2025-04-03T15:18:56+00:00 0.5 https://www.sciencehubpro.com/ch/articles/proven-efficacy-testosterone-replacement-therapy-sexual-function-and-hypogonadal-symptoms 2025-04-03T15:22:32+00:00 0.5 https://www.sciencehubpro.com/ch/articles/understanding-bvas-assessing-vasculitis-activity-clinical-practice 2026-01-23T13:11:15+00:00 0.5 https://www.sciencehubpro.com/ch/articles/conversation-prof-dr-jorg-latus-and-sydney-tang-new-therapy-options-iga-nephropathy 2025-10-02T12:41:41+00:00 0.5 https://www.sciencehubpro.com/ch/articles/economic-justification-cell-culture-based-influenza-vaccines-children-and-adults-review 2025-10-06T14:06:15+00:00 0.5 https://www.sciencehubpro.com/ch/articles/understand-benefits-and-risks-hormone-replacement-therapy-during-menopause 2025-10-06T14:04:35+00:00 0.5 https://www.sciencehubpro.com/ch/articles/menopause-and-hormonal-balance-what-you-need-know 2025-10-06T14:04:30+00:00 0.5 https://www.sciencehubpro.com/ch/articles/swiss-expert-guide-hormone-replacement-therapy-menopause 2025-10-06T14:04:24+00:00 0.5 https://www.sciencehubpro.com/ch/articles/structured-clinical-tool-assess-impact-menopausal-symptoms 2025-11-03T10:26:49+00:00 0.5 https://www.sciencehubpro.com/ch/articles/multimodal-prehabilitation-surgery-elderly-randomised-prospective-multicenter 2025-11-05T07:51:44+00:00 0.5 https://www.sciencehubpro.com/ch/articles/avacostar-pass-avacostar 2025-11-05T08:33:24+00:00 0.5 https://www.sciencehubpro.com/ch/articles/study-safety-and-activity-sparsentan-treatment-incident-patients-immunoglobulin 2025-11-05T08:48:33+00:00 0.5 https://www.sciencehubpro.com/ch/articles/swiss-kidney-biopsy-registry 2025-11-05T13:31:57+00:00 0.5 https://www.sciencehubpro.com/ch/articles/bvas-aktivitatsmessung-der-vaskulitis-der-klinischen-praxis-interaktiver-workshop 2026-01-23T13:59:15+00:00 0.5 https://www.sciencehubpro.com/ch/articles/vascularite-associee-aux-anca-vers-un-meilleur-controle 2026-01-23T13:48:58+00:00 0.5 https://www.sciencehubpro.com/ch/articles/anca-vaskulitis-auf-dem-weg-zu-besserer-kontrolle 2026-01-23T13:41:07+00:00 0.5 https://www.sciencehubpro.com/ch/articles/mehr-kontrolle-weniger-belastung-moderne-ansatze-in-der-behandlung-der-anca-assoziierten-vaskulitiden 2026-01-23T13:31:50+00:00 0.5 https://www.sciencehubpro.com/ch/articles/innovative-approaches-igan-therapy-summary-presentation 2026-01-29T12:05:30+00:00 0.5 https://www.sciencehubpro.com/ch/articles/gc-tapering-patients-receiving-avacopan 2026-01-29T12:01:38+00:00 0.5 https://www.sciencehubpro.com/therapy-areas daily 0.5 https://www.sciencehubpro.com/ch/therapy-areas daily 0.5 https://www.sciencehubpro.com/pt/therapy-areas daily 0.5 https://www.sciencehubpro.com/es/therapy-areas daily 0.5 https://www.sciencehubpro.com/ongoing-phase-IV-research daily 0.5 https://www.sciencehubpro.com/ch/ongoing-phase-IV-research daily 0.5 https://www.sciencehubpro.com/pt/ongoing-phase-IV-research daily 0.5 https://www.sciencehubpro.com/es/ongoing-phase-IV-research daily 0.5 https://www.sciencehubpro.com/vifor-pharma-congress-calendar daily 0.5 https://www.sciencehubpro.com/ch/vifor-pharma-congress-calendar daily 0.5 https://www.sciencehubpro.com/pt/vifor-pharma-congress-calendar daily 0.5 https://www.sciencehubpro.com/es/vifor-pharma-congress-calendar daily 0.5 https://www.sciencehubpro.com/therapy-areas/iron-deficiency daily 0.5 https://www.sciencehubpro.com/ch/therapy-areas/iron-deficiency daily 0.5 https://www.sciencehubpro.com/pt/therapy-areas/iron-deficiency daily 0.5 https://www.sciencehubpro.com/es/therapy-areas/iron-deficiency daily 0.5 https://www.sciencehubpro.com/therapy-areas/dialysis daily 0.5 https://www.sciencehubpro.com/ch/therapy-areas/dialysis daily 0.5 https://www.sciencehubpro.com/pt/therapy-areas/dialysis daily 0.5 https://www.sciencehubpro.com/es/therapy-areas/dialysis daily 0.5 https://www.sciencehubpro.com/therapy-areas/nephrology-and-rare-diseases daily 0.5 https://www.sciencehubpro.com/ch/therapy-areas/nephrology-and-rare-diseases daily 0.5 https://www.sciencehubpro.com/pt/therapy-areas/nephrology-and-rare-diseases daily 0.5 https://www.sciencehubpro.com/es/therapy-areas/nephrology-and-rare-diseases daily 0.5 https://www.sciencehubpro.com/therapy-areas/women-s-men-s-health daily 0.5 https://www.sciencehubpro.com/ch/therapy-areas/women-s-men-s-health daily 0.5 https://www.sciencehubpro.com/pt/therapy-areas/women-s-men-s-health daily 0.5 https://www.sciencehubpro.com/es/therapy-areas/women-s-men-s-health daily 0.5 https://www.sciencehubpro.com/therapy-areas/vaccines daily 0.5 https://www.sciencehubpro.com/ch/therapy-areas/vaccines daily 0.5 https://www.sciencehubpro.com/pt/therapy-areas/vaccines daily 0.5 https://www.sciencehubpro.com/es/therapy-areas/vaccines daily 0.5 https://www.sciencehubpro.com/ongoing-phase-IV-research/nephrology-and-rare-diseases daily 0.5 https://www.sciencehubpro.com/ch/ongoing-phase-IV-research/nephrology-and-rare-diseases daily 0.5 https://www.sciencehubpro.com/pt/ongoing-phase-IV-research/nephrology-and-rare-diseases daily 0.5 https://www.sciencehubpro.com/es/ongoing-phase-IV-research/nephrology-and-rare-diseases daily 0.5 https://www.sciencehubpro.com/ongoing-phase-IV-research/iron-deficiency daily 0.5 https://www.sciencehubpro.com/ch/ongoing-phase-IV-research/iron-deficiency daily 0.5 https://www.sciencehubpro.com/pt/ongoing-phase-IV-research/iron-deficiency daily 0.5 https://www.sciencehubpro.com/es/ongoing-phase-IV-research/iron-deficiency daily 0.5